TAK-875 versus placebo or glimepiride in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial.

Saved in:
Bibliographic Details
Title: TAK-875 versus placebo or glimepiride in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial.
Authors: Burant CF (AUTHOR), Viswanathan P (AUTHOR), Marcinak J (AUTHOR), Cao C (AUTHOR), Vakilynejad M (AUTHOR), Xie B (AUTHOR), Leifke E (AUTHOR)
Source: Lancet. 4/14/2012, Vol. 379 Issue 9824, p1403-1411. 9p.
Database: Psychology and Behavioral Sciences Collection
Description
ISSN:01406736
DOI:10.1016/s0140-6736(11)61879-5